RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, announces a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued innovation and growth in service of the company’s commitment to improving patient access to treatment, one prescription at a time. Founded in 2020 by pharmacists Gerard Rivera and Stephen Hom, RIS Rx was born out of their firsthand experience seeing the challenges and inefficiencies in administering patient affordability programs. The company’s technology-enabled solutions help pharmaceutical manufacturers’ patient assistance programs reach their intended recipients to support access and affordability.
Read the full article: RIS Rx Announces Growth Investment from Summit Partners to Combat Revenue Leakage in Pharma Patient Affordability Programs //
Source: https://www.businesswire.com/news/home/20250616509368/en/RIS-Rx-Announces-Growth-Investment-from-Summit-Partners-to-Combat-Revenue-Leakage-in-Pharma-Patient-Affordability-Programs